(PS2) Discussant

Disclosure(s):

Michael Lim, MD: Accuray: Research Grant (Ongoing); Arbor: Research Grant (Ongoing); Biohaven: Consultant (Ongoing), Research Grant (Ongoing); BMS: Consultant (Ongoing), Research Grant (Ongoing); Century Therapeutics: Consultant (Ongoing); CraniUs: Consultant (Ongoing); Egret Therapeutics: Ownership or Partnership (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Hemispherian: Consultant (Ongoing); InCando: Consultant (Ongoing); InCephalo: Consultant (Ongoing), Research Grant (Ongoing); InSightec: Consultant (Ongoing), Research Grant (Ongoing); MediFlix: Consultant (Ongoing); Merck: Consultant (Ongoing); Novocure, Inc.: Consultant (Ongoing), Research Grant (Ongoing); Noxxon: Consultant (Ongoing); Pyarmid Bio: Stock Shareholder (excluding mutual funds) (Ongoing); Sanianoia: Consultant (Ongoing), Grant/Research Support (Ongoing); VBI: Consultant (Ongoing)